Technical Analysis for COLL - Collegium Pharmaceutical, Inc.

Grade Last Price % Change Price Change
grade F 16.655 1.55% 0.26
COLL closed up 1.55 percent on Tuesday, July 14, 2020, on 1.15 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical COLL trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 1.55%
Bollinger Band Squeeze Range Contraction 1.55%
Bollinger Band Squeeze Range Contraction -0.45%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Pharmaceutical Diseases Pain Chemical Compounds Organic Compounds Euphoriants Chronic Pain Morphinans Platform Technology Attention Deficit Hyperactivity Disorder Opioids Ethers Phenols Hydrocodone Treatment Of Attention Deficit Hyperactivity Disorder Oxycodone Oxymorphone

Is COLL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.59
52 Week Low 10.01
Average Volume 448,415
200-Day Moving Average 18.78
50-Day Moving Average 19.42
20-Day Moving Average 17.38
10-Day Moving Average 17.09
Average True Range 1.01
ADX 28.48
+DI 10.86
-DI 24.41
Chandelier Exit (Long, 3 ATRs ) 15.86
Chandelier Exit (Short, 3 ATRs ) 18.87
Upper Bollinger Band 18.49
Lower Bollinger Band 16.27
Percent B (%b) 0.17
BandWidth 12.74
MACD Line -0.70
MACD Signal Line -0.73
MACD Histogram 0.0218
Fundamentals Value
Market Cap 492.43 Million
Num Shares 29.6 Million
EPS -3.59
Price-to-Earnings (P/E) Ratio -4.64
Price-to-Sales 40.60
Price-to-Book 3.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.92
Resistance 3 (R3) 17.78 17.23 17.71
Resistance 2 (R2) 17.23 16.91 17.30 17.63
Resistance 1 (R1) 16.94 16.71 17.09 17.08 17.56
Pivot Point 16.39 16.39 16.46 16.46 16.39
Support 1 (S1) 16.10 16.07 16.25 16.24 15.75
Support 2 (S2) 15.55 15.87 15.62 15.68
Support 3 (S3) 15.26 15.55 15.61
Support 4 (S4) 15.40